Global Point of Care/Rapid Diagnostic Market Size, Share, Growth, Demand, Analysis and Forecast 2027

The global Point of Care/Rapid Diagnostic Market size was valued USD 30 billion in 2020 and will reach USD 56.5 Billion by 2027 and is expected to develop at a CAGR of 11.5% during the forecast period, according to analysts. For the forecast year 2021-2027, as well as the historical period 2015-2020, the Point of Care/Rapid Diagnostic Market has been studied.

The research report provides a comprehensive and insightful examination of the global pyrogen testing and includes market analysis on segmentation, dynamics, competition, and regional development. It considers the Point of Care/Rapid Diagnostic Market's CAGR, value, volume, revenue, production, consumption, sales, manufacturing cost, pricing, and other significant parameters. The forecasts in the report are based on well-established research methodology and assumptions.

Explore the recent findings of this research by requesting a free sample PDF @ https://www.vynzresearch.com/healthcare/point-of-carerapid-diagnostic-market/request-sample

Individual strategies were examined in the global Point of Care/Rapid Diagnostic Market study, followed by business profiles of pyrogen testing industry providers. The study includes an 'Industry Landscape' section that provides readers with a comprehensive view and firms’ market share analysis of major industry players in the Point of Care/Rapid Diagnostic Market.

Most of the major players in the Point of Care/Rapid Diagnostic Market are profiled in the report. The strengths and weaknesses, business developments, recent innovations, mergers and acquisitions, expansion plans, global footprint, market presence, and product portfolios of key market competitors are all covered in the company profiling section.

The following are some of the major and developing players in the Point of Care/Rapid Diagnostic Market:

• Abbott Laboratories

• Danaher Corporation

• Accubiotech

• Johnson & Johnson

• Becton

• Dickinson and Company

• EKF Diagnostics

• Nova Biomedical

• Quidel

• Roche Diagnostics

• Chembio Diagnostics

• PTS Diagnostics

• Instrumentation Laboratory

Breakdown of The Segments:

The Global Point of Care/Rapid Diagnostic Market is segmented by Product, by Platform, by Prescription Mode, and by End-User in this study. This segmentation aids executives in planning their products and budgets depending on each segment's expected growth rates.

By Product:

• Coagulation Testing

• Glucose Monitoring

• Tumor/Cancer Marker Testing

• Cardiometabolic Testing

• Pregnancy and Fertility Testing

• Infectious Disease Testing

• Urinalysis Testing

• Drugs-of-Abuse Testing

• Cholesterol Testing

• Fecal Occult Testing

• Hematology Testing

• Others

By Platform:

• Lateral Flow Assays

• Molecular Diagnostics

• Dipsticks

• Immunoassays

• Microfluidics

By Prescription Mode:

• OTC Testing

• Prescription-Based Testing

By End-User

• Research Laboratories

• Professional Diagnostic Centers

• Home Care

• Others

Ask for Customization of this Research Report at https://www.vynzresearch.com/healthcare/point-of-carerapid-diagnostic-market/customize-report

Geographical Viewpoint:

The research overview provides the major industry trend and the global market's predicted volume based on the regional analysis. The elements that have driven and hampered the market's expansion are also mentioned in this market research analysis. The study is also equipped with the most advanced and effective techniques for gathering, recording, estimating, and evaluating market data.

FAQ’s:

1. Who are the most dominant players in the global market, and what elements are assisting them in gaining a competitive advantage?

2. What are the strategies adopted by the key industry players to gain traction in the industry?

3. By the end of the forecast period, what will the market size and growth rate?

4. What is the biggest Point of Care/Rapid Diagnostic Market trends that are influencing market growth?

5. In the global market, which segment had the biggest revenue share?